Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M151,662Revenue (TTM) $M26,710Net Margin (%)24.8Altman Z-Score2.6
Enterprise Value $M181,694EPS (TTM) $4.1Operating Margin %36.7Piotroski F-Score5
P/E(ttm)23.4Beneish M-Score-2.5Pre-tax Margin (%)31.6Higher ROA y-yN
Price/Book25.210-y EBITDA Growth Rate %--Quick Ratio1.3Cash flow > EarningsY
Price/Sales5.85-y EBITDA Growth Rate %9.5Current Ratio1.4Lower Leverage y-yY
Price/Free Cash Flow23.1y-y EBITDA Growth Rate %19.0ROA % (ttm)9.9Higher Current Ratio y-yN
Dividend Yield %2.7PEG2.5ROE % (ttm)119Less Shares Outstanding y-yY
Payout Ratio %59.0Shares Outstanding M1,594ROIC % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with ABBV

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

ABBV is held by these investors:

ABBV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Michael Robert A.VP, Controller 2017-09-28Sell6,699$889.2view
SALEKI-GERHARDT AZITASVP, Operations 2017-09-11Sell8,300$85.0213.03view
GONZALEZ RICHARD AChairman of the Board and CEO 2017-08-07Sell193,131$7135.35view
GONZALEZ RICHARD AChairman of the Board and CEO 2017-08-04Sell87,899$71.0235.31view
Gosebruch Henry OChief Strategy Officer 2017-07-31Sell300$70.4236.47view
Gosebruch Henry OChief Strategy Officer 2017-07-31Sell18,000$70.0937.11view
RAPP EDWARD JDirector 2017-07-31Buy4,000$70.4536.41view
Schumacher Laura JExecutive Vice President 2017-06-14Sell79,800$7037.29view
ALBAN CARLOSEVP, Commercial Operations 2017-06-14Sell45,800$7037.29view
GONZALEZ RICHARD AChairman of the Board and CEO 2017-05-19Sell71,235$65.4946.74view

Press Releases about ABBV :

Quarterly/Annual Reports about ABBV:

News about ABBV:

Articles On GuruFocus.com
AbbVie to Present at the 2017 Credit Suisse Health Care Conference Oct 18 2017 
AbbVie and Harpoon Therapeutics Announce Immuno-Oncology Research Collaboration Oct 18 2017 
Fundamental Equity Analysis – Consolidated Research on Johnson & Johnson, Home Depot, Adobe, Di Oct 13 2017 
AbbVie Demonstrates Leadership in HCV with New MAVYRET™ (glecaprevir/pibrentasvir) Data to be Pres Oct 11 2017 
AbbVie and Turnstone Biologics Announce Global Collaboration on Viral Immunotherapies in Oncology Oct 10 2017 
AbbVie to Host Third-Quarter 2017 Earnings Conference Call Oct 09 2017 
Analysts Act on Health Care Stocks Oct 03 2017 
AbbVie, Amgen Resolve Humira Patent Dispute Sep 29 2017 
BlackBerry Surges on Earnings Beat Sep 28 2017 
AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Amgen Sep 28 2017 

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat